{
  "id": 20271365,
  "title": "Glenmark launches generic Inlyta tablets for kidney cancer treatment in US",
  "url": "https://urgent.news/2026/11/16/glenmark-launches-generic-inlyta-tablets-for-kidney-cancer-treatment",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-16T06:53:42.000Z",
  "source": {
    "name": "Business Standard IN",
    "slug": "business-standard-in",
    "url": "https://www.business-standard.com/companies/news/glenmark-launches-generic-inlyta-tablets-for-kidney-cancer-treatment-in-us-126111600879_1.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Glenmark Axitinib tablets (a generic equivalent to Pfizer's Inlyta) are used to treat advanced renal cell carcinoma (RCC), a type of kidney cancer",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}